Crizotinib fails to improve disease-free survival in resected early-stage ALK+ non-small cell lung cancer

Updated on: September 30,2025 0

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ non-small cell lung cancer

Updated on:September 30,2025 0

Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study

Updated on: August 10,2025 0

Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study

Updated on:August 10,2025 0

Stevia leaf extract has potential as anticancer treatment, researchers find

Updated on: August 11,2025 0

Stevia leaf extract has potential as anticancer treatment, researchers find

Updated on:August 11,2025 0

Unexpected side effect: How common medications clear the way for pathogens

Updated on: August 08,2025 0

Unexpected side effect: How common medications clear the way for pathogens

Updated on:August 08,2025 0

How brain fluid dynamics drive cancer spread—and ways to fight back

Updated on: October 03,2025 0

How brain fluid dynamics drive cancer spread—and ways to fight back

Updated on:October 03,2025 0

How accurately are racial minorities represented in US cancer registration systems?

Updated on: August 12,2025 0

How accurately are racial minorities represented in US cancer registration systems?

Updated on:August 12,2025 0

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Updated on: September 30,2025 0

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Updated on:September 30,2025 0

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Updated on: October 03,2025 0

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Updated on:October 03,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on: October 04,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on:October 04,2025 0

A microbial DNA signature differentiates two types of cancer in the liver

Updated on: September 05,2025 0

A microbial DNA signature differentiates two types of cancer in the liver

Updated on:September 05,2025 0